Clinical Trials Logo
  1. Home
  2. Alcoholic Cirrhosis
  3. NCT05093881

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

Alcoholic Cirrhosis Clinical Trial

Official title:
Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

Clinical Trial Summary

This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.

Clinical Trial Description

To evaluate the safety for 60 months after a single dose of Cellgram-LC in patients with alcoholic liver cirrhosis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05093881
Study type Interventional
Source Pharmicell Co., Ltd.
Contact JIYEOUN JEONG
Phone 82-2-3496-0134
Email jyjeong@pharmicell.com
Status Recruiting
Phase N/A
Start date August 24, 2021
Completion date March 31, 2028
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04106518 - Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease
Completed NCT01065233 - Pangenomic Study During Alcoholic Cirrhosis
Recruiting NCT04250259 - SAMe Trial for Patients With Alcoholic Cirrhosis Phase 2
Active, not recruiting NCT01213927 - National Cohort of Uncomplicated Alcoholic Cirrhosis
Completed NCT00388323 - Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human N/A
Terminated NCT01342705 - Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis Phase 3
Recruiting NCT04689152 - Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis Phase 3
Recruiting NCT05155657 - Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells Phase 1
Terminated NCT03534141 - Mild Hypothermia and Acute Kidney Injury in Liver Transplantation N/A
Completed NCT02072746 - Zinc Supplementation in Alcoholic Cirrhosis N/A
Completed NCT00827723 - Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma
Recruiting NCT04245189 - EUS Based Prevalence of Chronic Pancreatitis in Alcoholic Cirrhosis
Completed NCT01756794 - Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment N/A
Terminated NCT03508388 - Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis
Completed NCT02326103 - Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis Phase 0
Terminated NCT00188045 - Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients Phase 4
Withdrawn NCT04070508 - Early Detection of Alcoholic Liver Disease
Recruiting NCT04363424 - Alcohol Biomarker Study